
QNCX
USDQuince Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.560
Kõrge
$1.620
Madal
$1.555
Maht
0.11M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
85.9M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.27M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation of
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target
D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics with a Buy and maintains $4 price target.
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study
Quince Therapeutics, Inc.
Seotud aktsiad
EBMT
Eagle Bancorp Montana Inc.
GLU
Gabelli Global Utility Common Shares of Beneficial Ownership
HNRG
Hallador Energy Company
EPRT
Essential Properties Realty Trust Inc.
BR
Broadridge Financial Solutions Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.